BICALUTAMIDE TEVA 50 mg
 |
|
|
Package:
TABLETS: 30.
Dosage:
The tablets should not be chewed or crushed. The tablets should not be divided since there is no score line.
Adult males including the elderly: 1 tablet (50 mg) 1 x daily.
Treatment should be started at least 3 days before commencing treatment with an LHRH analog, or at the same time as surgical castration.
Renal impairment: No dosage adjustment is necessary.
Hepatic impairment: No dosage adjustment is necessary for patients with mild hepatic impairment. Increased accumulation may occur in patients with moderate to severe hepatic impairment.
Prescribing Restrictions:
Indications:
Treatment of advanced prostate cancer in combination with LHRH analogue therapy or surgical castration.
Contra-Indications:
Females and children. Must not be given to any patient who has shown a hypersensitivity to the active substance or any of the excipients. Co-administration of terfenadine, astemizole or cisapride is contraindicated .
Special Precautions:
See literature. Please contact distributor for full information.
Side Effects:
See literature. Please contact distributor for full information.
Drug Interactions:
See literature. Please contact distributor for full information.
